Takeda Pharmaceutical Co Ltd
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.9% | 31.7% | 32.3% | 27.0% | 28.1% | 29.1% | 27.7% | 26.8% | 25.7% | 27.7% | 40.4% | 35.4% | 33.5% | 32.5% | 32.2% | 29.7% | 31.6% | 30.3% | 32.9% | 25.4% | 32.6% | 31.2% | 35.3% | 30.1% | 30.5% | 30.6% | 32.4% | 30.3% | 32.9% | 34.2% | 36.9% | 32.0% | 33.5% | 36.4% | 36.3% | 34.8% | 34.2% | 45.6% | 51.2% | 33.3% | 41.0% | |
| 66.1% | 68.3% | 67.7% | 73.0% | 71.9% | 70.9% | 72.3% | 73.2% | 74.3% | 72.3% | 59.6% | 64.6% | 66.5% | 67.5% | 67.8% | 70.3% | 68.4% | 69.7% | 67.1% | 74.6% | 67.4% | 68.8% | 64.7% | 69.9% | 69.5% | 69.4% | 67.6% | 69.7% | 67.1% | 65.8% | 63.1% | 68.0% | 66.5% | 63.6% | 63.7% | 65.2% | 65.8% | 54.4% | 48.8% | 66.7% | 59.0% | |
| 18.1% | 15.4% | 21.3% | 16.9% | 18.3% | 16.7% | 22.1% | 16.0% | 18.4% | 15.5% | 19.4% | 13.8% | 14.0% | 14.3% | 18.1% | 13.3% | 15.0% | 14.1% | 14.7% | 12.9% | 15.6% | 14.2% | 16.4% | 14.8% | 15.4% | 15.9% | 16.8% | 15.4% | 17.6% | 16.9% | 18.6% | 13.9% | 14.9% | 14.9% | 20.5% | 13.0% | 14.5% | 14.7% | 17.8% | 13.7% | 15.2% | |
| 35.0% | – | – | 32.5% | 35.0% | 0.3% | 0.4% | 32.2% | 34.5% | 0.3% | 37.6% | 28.2% | 27.5% | 29.0% | 26.2% | 25.2% | 27.4% | 26.6% | 30.4% | 23.2% | 25.1% | 25.6% | 25.6% | 23.8% | 24.8% | 23.9% | 26.6% | 23.4% | 24.3% | 24.1% | 27.1% | 22.4% | 22.8% | 23.7% | 28.1% | 23.1% | 22.8% | 23.3% | 26.2% | 23.5% | 23.9% | |
| 63.9% | 56.4% | 82.5% | 29.5% | 62.8% | 52.8% | 92.4% | 51.2% | 57.3% | 49.7% | 76.9% | 63.4% | 61.5% | 61.2% | 75.9% | 49.4% | 62.2% | 52.6% | 47.6% | 48.4% | 55.8% | 55.9% | 64.9% | 54.4% | 59.1% | 56.0% | 58.3% | 53.7% | 71.8% | 56.4% | 64.1% | 54.2% | 50.8% | 57.7% | 70.8% | 48.6% | 59.6% | 38.4% | 44.5% | 50.2% | 48.0% | |
| 2.2% | 11.9% | -14.8% | 43.5% | 9.1% | 18.0% | -20.1% | 22.0% | 17.0% | 22.5% | -11.1% | 1.2% | 5.0% | 6.2% | -8.1% | 20.9% | 6.1% | 17.1% | 19.5% | 26.2% | 11.5% | 12.9% | -0.2% | 15.5% | 10.4% | 13.4% | 9.3% | 15.9% | -4.7% | 9.4% | -1.0% | 13.8% | 15.7% | 5.9% | -7.1% | 16.7% | 6.2% | 16.0% | 4.3% | 16.5% | 11.0% | |
| 1.4% | 1.3% | 1.5% | 2.2% | 1.4% | 1.4% | 2.3% | 3.3% | 2.1% | 4.5% | 0.9% | 5.4% | 6.6% | 5.1% | 0.1% | 5.8% | 8.1% | 7.5% | 10.2% | 7.5% | 4.7% | 5.2% | 2.8% | 5.7% | 5.4% | 7.3% | 0.0% | 5.6% | 0.0% | 6.0% | 0.0% | 4.9% | 5.8% | 0.0% | 0.0% | 9.7% | 7.5% | 10.4% | 4.0% | 5.2% | 6.8% | |
| 1.3% | 11.6% | -15.7% | 44.2% | 8.0% | 11.2% | -17.6% | 20.9% | 15.5% | 9.5% | -15.8% | -3.0% | -0.3% | 2.9% | -15.1% | 16.2% | -0.6% | 13.1% | 17.0% | 23.5% | 7.3% | 8.0% | -6.2% | 16.0% | 6.5% | 9.8% | 5.0% | 12.8% | -9.2% | 5.5% | -4.5% | 11.3% | 10.2% | 2.3% | -10.2% | 13.6% | 2.5% | 11.2% | -4.8% | 13.3% | 5.9% | |
| -4.8% | 2.4% | -3.1% | 11.9% | 1.6% | -2.7% | -4.2% | 3.5% | 4.3% | 1.9% | -8.1% | -0.5% | -6.9% | 6.6% | -15.3% | 6.0% | -1.1% | 2.1% | -8.6% | 9.0% | 1.8% | 1.6% | -4.9% | 5.2% | 0.3% | -1.1% | 1.8% | 4.3% | -4.6% | -4.0% | -4.2% | 3.4% | 2.3% | 0.2% | -0.4% | 2.4% | 3.6% | 2.5% | -2.6% | 4.1% | 2.0% | |
| 5.9% | 8.9% | -12.2% | 32.3% | 6.5% | 13.9% | -13.5% | 17.4% | 11.2% | 7.6% | -7.7% | -2.4% | 6.6% | -3.7% | 0.2% | 10.3% | 0.5% | 11.0% | 25.6% | 14.5% | 5.4% | 6.4% | -1.3% | 10.8% | 6.2% | 10.9% | 3.3% | 8.4% | -4.6% | 9.5% | -0.3% | 7.9% | 7.8% | 2.1% | -9.8% | 11.2% | -1.1% | 8.7% | -2.2% | 9.3% | 3.9% | |
| 17.7% | 21.8% | -1.9% | 56.7% | 17.9% | 21.6% | -5.5% | 32.7% | 26.8% | 21.7% | 11.8% | 23.2% | 26.7% | 19.1% | 7.0% | 39.7% | 23.7% | 33.8% | 25.3% | 46.0% | 28.6% | 29.5% | 15.0% | 38.0% | 28.6% | 33.2% | 20.9% | 34.6% | 19.4% | 23.1% | 24.7% | 32.2% | 32.3% | 16.9% | 17.2% | 39.7% | 28.4% | 37.6% | 14.2% | 27.7% | 27.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.